Incyte (Nasdaq: INCY) today announced that multiple abstracts featuring new data from its dermatology portfolio will be presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting ...

Another former St Virgil’s student has told a Hobart courtroom his memory of the night over 40 years ago that a classmate was ...

The current measles vaccine was developed in 1968 after the original was created in 1963. It is the only measles vaccine used in the U.S. It is usually combined with mumps and rubella (MMR) or mumps, ...

American Academy of Dermatology President Seemal R. Desai, MD, FAAD ...

Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease ...

ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor currently under development in moderate-to-severe plaque ...

The I-neb is the third generation AAD (Adaptive Aerosol Delivery) system. It is a small, battery powered, lightweight and virtually silent drug delivery device designed to significantly reduce the ...

Fair Isaac Corp. closed 25.08% short of its 52-week high of $2,402.52, which the company reached on November 13th.

Seemal R Desai, MD, FAAD, president of the American Academy of Dermatology (AAD), emphasized his commitment to enhancing the upcoming 2025 annual meeting by introducing new events and expanding ...

Chartbeat, a leading media operations software platform, backed by Cuadrilla Capital, LLC ("Cuadrilla"), today announced that ...

This research analyzes AI investment's impact on sustainable development in the U.S., highlighting its role in economic ...